Global Menopause Market Overview
Menopause is the term used to describe the end of a woman's menstrual cycle. After a 12-month time without a menstrual period, it's diagnosed. Menopause can strike in your 40s or 50s, but in the United States, the average age is 51. Menopause is a normal part of the female reproductive system. However, menopause's physical and mental symptoms, like as hot flashes, can disrupt your sleep, diminish your energy, and damage your emotional health. From lifestyle changes to hormone medication, there are a variety of effective therapies available. Menopausal heat flashes are one of the menopause symptoms. They relate to the sensations of warmth that women experience as they approach menopause. In addition, hot flashes are the most common symptom of menopause and perimenopause, when ovaries gradually make less estrogen. In addition, hot flashes are the most common symptom of menopause and perimenopause, when ovaries gradually make less estrogen. The Global Menopause market accounted for US$ 10.67 billion in 2020 and is estimated to be US$ 16.46 billion by 2030 and is anticipated to register a CAGR of 4.5%.
Global Menopause Market Dynamics
Increasing incidence of menopausal hot flashes
The primary driving factors for the menopausal heat flashes market are the rising incidence of menopausal hot flashes, the increasing number of new pharmacological approvals for the treatment, and rising knowledge about menopause health. Hot flashes are a quick sensation of warmth that mainly affects the chest, neck, and face. Hot flashes produce flushing (redness of the skin) and profuse sweating. Menopause causes hot flashes, which occur when menstrual periods become erratic and eventually stop. Hot flashes are, in fact, the most prevalent symptom of menopausal transition (which includes stages such as pre-menopause, perimenopause, and post-menopause). Hot flashes can last from a few minutes to many hours, depending on the woman. Rapid heartbeat, flushed appearance with red, blotchy skin, perspiration, particularly on the upper body, a sudden feeling of warmth spreading through the upper body and face, and so on are some of the signs of a hot flash. The strength and frequency of hot flashes might vary. Hot flashes symptoms last on average for more than seven years, and in some women, they can last up to ten years. Hot flashes are produced by changes in reproductive hormones, which become more sensitive to minor temperature changes. Smoking, weight, and ethnicity are all factors that may raise the risk of hot flashes.
High amount of stress and mental health
Individual health has been harmed by the COVID-19 epidemic. Menopausal symptoms have become more severe as a result of increased stress and mental health issues, as well as hormonal imbalance. The pandemic and the consequent lockdown restrictions have raised public awareness about health and the usefulness of items like nutritional supplements in boosting health, particularly managing menopausal symptoms. Dietary supplement use surged during the pandemic, according to the results of a survey done by the Council for Responsible Nutrition (CRN), a trade organisation for the functional food and dietary supplement sector, in August 2020.
Global Menopause Market Segmentation
The Global Menopause market is segmented based on treatment, distribution channel and region.
On the basis of treatment, the Global Menopause market is segmented into Hormonal Treatment (Estrogen, Progesterone and Combination), Non-Hormonal Treatment (Anti-Depressants). Based on distribution channel, the target market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Stores.
Regional Insights:
On region the Global Menopause market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to hold a significant market share in the menopausal market because of the rising incidence of menopausal hot flashes, increased awareness of menopause health, and the existence of a bigger percentage of older women in the general population in this region. According to the North American Menopause Society, roughly 75 percent of North American women suffer hot flashes during perimenopause, and about a quarter of them are bothered enough to seek medical help. In addition, according to a study published in NCBI in 2020 by Kimberly Peacock et al., around 1.3 million women in the United States enter menopause each year which begins between the ages of 51 and 52 years. Moreover, roughly 5% of women between the ages of 40 and 45 experience early menopause. The United States has been the most affected country in the globe by COVID-19. This country's product supply chain was severely damaged. Initially, there was a drop in demand for hot flash products, which slowed the market's overall growth. However, import-export limitations have been eased recently, opening up new growth opportunities for the predicted period.
Report Scope:
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2029 |
|
Market Segmentation |
By Treatment- Hormonal Treatment (Estrogen, Progesterone and Combination), Non-Hormonal Treatment (Anti-Depressants) By Distribution Channel– Hospital Pharmacies, Retail Pharmacies and Online Stores |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Menopause market report based on treatment, distribution channel and region.
Global Menopause market, By Region:
-
-
- North America
-
- U.S.
- Canada
-
- Europe
-
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
-
- Asia Pacific
-
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
-
- Latin America
-
- Brazil
- Mexico
- Rest of Latin America
-
- Middle East & Africa
-
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
-
- North America
-
Global Menopause Market Key Players
The menopausal hot flashes market is fragmented and competitive and consists of several major players. A large portion of the market share is taken up by small and mid-sized companies that produce generic treatment options. Some of the companies currently dominating the market are AbbVie Inc. (Allergan PLC), Bayer AG, Novartis AG, Pfizer Inc., Novo Nordisk Corporation, Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., and Teva Pharmaceutical Industries Ltd.
Global Menopause Market Company Profile
- AbbVie Inc. (Allergan PLC)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Novo Nordisk Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hisamitsu Pharmaceutical Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
Global Menopause Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Menopause Strategies
- Key Questions this Study will Answer
- Market Snippet, By Treatment
- Market Snippet, By Distribution Channel
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Menopause market, By Treatment, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hormonal Treatment
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Non-Hormonal Treatment
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Menopause market, By Distribution Channel, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Retail Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Online Stores
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Menopause market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Treatment, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
- AbbVie Inc. (Allergan PLC)
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Bayer AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Novo Nordisk Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Hisamitsu Pharmaceutical Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- The Last Word
- Future Impact
- About Us
- Contact
FAQs
The Global Menopause market is segmented based on treatment, distribution channel and region.
High amount of stress and mental health is the major factor driving growth of the global market
The market in North America is expected to hold the largest share in the Global Menopause market.
Some of the companies currently dominating the market are AbbVie Inc. (Allergan PLC), Bayer AG, Novartis AG, Pfizer Inc., Novo Nordisk Corporation, Hisamitsu Pharmaceutical Co. Inc., Merck & Co. Inc., and Teva Pharmaceutical Industries Ltd.